Abstract: Starting from the “Hygiene Hypothesis” to the “Microflora hypothesis” we provided an overview of the symbiotic and dynamic equilibrium between microbiota and the immune system, focusing on the role of dysbiosis in atopic march, particularly on allergic rhinitis. The advent of deep sequencing technologies and metabolomics allowed us to better characterize the microbiota diversity between individuals and body sites. Each body site, with its own specific environmental niches, shapes the microbiota conditioning colonization and its metabolic functionalities. The analysis of the metabolic pathways provides a mechanistic explanation of the remote mode of communication with systems, organs, and microflora of other body sites, including the ecosystem of the upper respiratory tract. This axis may have a role in the development of respiratory allergic disease. Notably, the microbiota is significant in the development and maintenance of barrier function; influences hematopoiesis and innate immunity; and shows its critical roles in Th1, Th2, and Treg production, which are necessary to maintain immunological balance and promote tolerance, taking part in every single step of the inflammatory cascade. These are microbial biotherapy foundations, starting from probiotics up to postbiotics and parabiotics, in a still-ongoing process. When considering the various determinants that can shape microbiota, there are several factors to consider: genetic factors, environment, mode of delivery, exposure to antibiotics, and other allergy-unrelated diseases. These factors hinder the engraftment of probiotic strains but may be upgradable with postbiotic and parabiotic administration directly on molecular targets. Supplementation with postbiotics and parabiotics could represent a very exciting perspective of treatment, bypassing probiotic limitations. At present, this avenue remains theoretical and to be explored, but it will certainly be a fascinating path to follow.

(R)Evolution in allergic rhinitis add-on therapy. from probiotics to postbiotics and parabiotics / Capponi, Martina; Gori, Alessandra; DE CASTRO, Giovanna; Ciprandi, Giorgio; Anania, Caterina; Brindisi, Giulia; Loffredo, Lorenzo; Tosca, Mariangela; Cinicola, BIANCA LAURA; Salvatori, Alessandra; Spalice, Alberto; Zicari, Anna Maria. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:17(2022). [10.3390/jcm11175154]

(R)Evolution in allergic rhinitis add-on therapy. from probiotics to postbiotics and parabiotics

Martina Capponi
;
Giovanna De Castro;Caterina Anania;Giulia Brindisi;Lorenzo Loffredo;Bianca Laura Cinicola;Alessandra Salvatori;Alberto Spalice;Anna Maria Zicari
2022

Abstract

Abstract: Starting from the “Hygiene Hypothesis” to the “Microflora hypothesis” we provided an overview of the symbiotic and dynamic equilibrium between microbiota and the immune system, focusing on the role of dysbiosis in atopic march, particularly on allergic rhinitis. The advent of deep sequencing technologies and metabolomics allowed us to better characterize the microbiota diversity between individuals and body sites. Each body site, with its own specific environmental niches, shapes the microbiota conditioning colonization and its metabolic functionalities. The analysis of the metabolic pathways provides a mechanistic explanation of the remote mode of communication with systems, organs, and microflora of other body sites, including the ecosystem of the upper respiratory tract. This axis may have a role in the development of respiratory allergic disease. Notably, the microbiota is significant in the development and maintenance of barrier function; influences hematopoiesis and innate immunity; and shows its critical roles in Th1, Th2, and Treg production, which are necessary to maintain immunological balance and promote tolerance, taking part in every single step of the inflammatory cascade. These are microbial biotherapy foundations, starting from probiotics up to postbiotics and parabiotics, in a still-ongoing process. When considering the various determinants that can shape microbiota, there are several factors to consider: genetic factors, environment, mode of delivery, exposure to antibiotics, and other allergy-unrelated diseases. These factors hinder the engraftment of probiotic strains but may be upgradable with postbiotic and parabiotic administration directly on molecular targets. Supplementation with postbiotics and parabiotics could represent a very exciting perspective of treatment, bypassing probiotic limitations. At present, this avenue remains theoretical and to be explored, but it will certainly be a fascinating path to follow.
2022
probiotics; postbiotics; parabiotic; allergic rhinitis; immune system; microbiota; atopic march; allergic disease; allergic inflammation
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
(R)Evolution in allergic rhinitis add-on therapy. from probiotics to postbiotics and parabiotics / Capponi, Martina; Gori, Alessandra; DE CASTRO, Giovanna; Ciprandi, Giorgio; Anania, Caterina; Brindisi, Giulia; Loffredo, Lorenzo; Tosca, Mariangela; Cinicola, BIANCA LAURA; Salvatori, Alessandra; Spalice, Alberto; Zicari, Anna Maria. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 11:17(2022). [10.3390/jcm11175154]
File allegati a questo prodotto
File Dimensione Formato  
Capponi_(R)Evolution_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 317.14 kB
Formato Adobe PDF
317.14 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1654188
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact